Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Intervalo de ano de publicação
1.
Materials (Basel) ; 15(1)2021 Dec 22.
Artigo em Inglês | MEDLINE | ID: mdl-35009209

RESUMO

The potential use of amino acids by ruminal microorganisms converting them into microbial protein for ruminants makes it challenging to supplement these nutrients in an accessible form in animals' diets. Several strategies to protect amino acids from ruminal degradation were reported, producing amino acids available for the protein used in the intestine called "bypass." The intercalation of biomolecules in clay mineral minerals has gained notoriety due to its ability to support, protect, transport, physicochemical properties and non-toxicity. This study aimed to investigate the incorporation of L-lysine (Lys), L-methionine (Met), and L-tryptophan (Trp) amino acids in the clay minerals sepiolite (Sep) and Veegum® (Veg) using the adsorption method. The characterization techniques of X-ray diffraction and infrared spectroscopy indicated the presence of biomolecules in the inorganic matrices. Elemental and thermal analyzes monitored the percentages of incorporated amino acids. They showed better incorporation capacities for Veg, such as Met-Veg < Lys-Veg < Trp-Veg and Lys-Sep < Met-Sep < Trp-Sep for sepiolite, except for the incorporation of Met. Matrices provide a promising alternative for planning the administration of biomolecules, using essential amino acids as models, and may offer an alternative to improve functional diet strategies.

2.
Pesqui. vet. bras ; 38(3): 456-461, mar. 2018. tab, graf
Artigo em Inglês | LILACS, VETINDEX | ID: biblio-964880

RESUMO

Two experiments were conducted to evaluate the impact of two vaccines on the reproductive performance of multiparous beef cows in Mato Grosso do Sul, Midwest Brazil. In Experiment 1,765 calved multiparous Nellore cows were subjected to the same fixed-time artificial insemination (FTAI) protocol and rebred. Ultrasound pregnancy diagnosis was performed 30 and 90 days post-FTAI (DPI). Rates of pregnancy and pregnancy loss were determined for three periods: from 30 to 90 DPI, from 30 DPI to calving, and from 90 DPI to calving. The cows were assigned to three groups with different vaccination protocols - namely, Group VACMULT (n=250): vaccine against bovine herpesvirus 1 (BoHV-1), bovine viral diarrhea virus (BVDV), and leptospirosis; Group VACL (n=245): vaccine against leptospirosis alone; Group NOVAC (n=270): no vaccination. Serum antibody titers for BoHV-1, BVDV, and leptospirosis, measured in 57 cows from each group indicated active infection, suggesting circulation of these pathogens in the herd. No differences in pregnancy rates were observed across groups. Pregnancy loss rates did not differ significantly across groups within any of the periods investigated (30 to 90 DPI, 30 DPI to calving, or 90 DPI to calving). In Experiment 2, two vaccination protocols for each vaccine were investigated. Group VACGEST was vaccinated on day zero of FTAI (D0) and again 30 days post-FTAI (30 DPI). Group VACPREV was vaccinated on D0 and again on the day of insemination (D11). No significant difference was observed between groups, or significant gestational loss in the group that received the second vaccine on the day of insemination. The results revealed that neither vaccine interfered with the reproductive performance of multiparous cows. No differences were observed between vaccination carried out on both D0 and D11 and that performed on both D0 and D30. The performance of the IBR/BVDV/Leptospirosis vaccine on the day of the artificial insemination did not cause adverse effects on the reproductive parameters.(AU)


Foram delineados dois experimentos para avaliar o impacto de duas vacinas no desempenho reprodutivo de vacas multíparas de bovinos de corte em Mato Grosso do Sul, Centro-Oeste do Brasil. No Experimento 1 foram utilizadas 765 vacas multíparas paridas da raça Nelore submetidas ao mesmo protocolo de inseminação artificial em tempo fixo (IATF) e repassadas por touros. O diagnóstico de gestação por ultrassonografia foi realizado aos 30 e 90 dias pós IATF. A prenhez e a taxa de perda de gestação foram determinadas para três períodos: de 30 a 90 DPI, de 30 DPI até para o parto e de 90 DPI até o parto. As vacas foram distribuídas em três grupos: grupo VACMULT (n=250), vacinado com vacina contra herpesvírus bovino tipo 1 (BoHV-1), vírus da diarreia viral bovina (BVDV) e leptospirose; grupo VACL (n=245), vacinado somente contra leptospirose; e grupo NOVAC (n=270), não vacinado. Títulos de anticorpos no soro de 57 vacas de cada grupo evidenciaram infecção por BoHV-1, BVDV e leptospirose, sugerindo circulação desses patógenos no rebanho. No diagnóstico por ultrassonografia, a prenhez não diferiu em nenhum dos três grupos. A taxa de perda de gestação não diferiu significantemente entre os grupos e dentro de qualquer um dos períodos investigados (30 a 90 DPI, 30 DPI até o parto ou 90 DPI até o parto). No Experimento 2 foram testados dois protocolos de vacinação usando as vacinas contra IBR/BVDV/leptospirose e somente contra leptospirose em ambos. No grupo VACGEST as vacas foram vacinas no dia zero (D0) do protocolo da IATF e 30 dias pós- IATF (30 DPI). No grupo VACPREV a primeira dose foi administrada no D0 e a segunda no mesmo dia da IATF (D11). Não houve diferença significativa entre os grupos, nem perda gestacional significativa no grupo que recebeu a segunda vacina no dia da inseminação (VACPREV). Os resultados mostram que as vacinas contra IBR/BVDV/leptospirose e somente contra leptospirose não interferiram no desempenho reprodutivo de vacas multíparas. Não houve diferença significativa entre o protocolo de vacinação empregado em D0 e D11 e aquele utilizado em D0 e 30 DPI. A realização da vacina contra IBR/BVD/leptospirose no dia da inseminação artificial não provocou efeitos adversos nos parâmetros reprodutivos.(AU)


Assuntos
Animais , Bovinos , Vacinação/veterinária , Comportamento Reprodutivo/fisiologia
3.
Am J Respir Crit Care Med ; 195(1): 32-42, 2017 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-27744739

RESUMO

RATIONALE: Clinical control is difficult to achieve in obese patients with asthma. Bariatric surgery has been recommended for weight loss and to improve asthma control; however, the benefits of nonsurgical interventions have been poorly investigated. OBJECTIVES: To examine the effect of exercise training in a weight-loss program on asthma control, quality of life, inflammatory biomarkers, and lung function. METHODS: Fifty-five obese patients with asthma were randomly assigned to either a weight-loss program plus exercise (WL + E group, n = 28) or a weight-loss program plus sham (WL + S group, n = 27), where the weight-loss program included nutrition (caloric restriction) and psychological therapies. The WL + E group incorporated aerobic and resistance muscle training, whereas the WL + S group incorporated breathing and stretching exercises. MEASUREMENTS AND MAIN RESULTS: The primary outcome was clinical improvement in asthma control over 3 months. Secondary outcomes included quality of life, lung function, body composition, aerobic capacity, muscle strength, and inflammatory/antiinflammatory biomarkers. After 3 months, 51 patients were analyzed. Compared with the WL + S group, the WL + E group demonstrated improved clinical control scores (median [25th to 75th percentile], -0.7 [-1.3 to -0.3] vs. -0.3 [-0.9 to 0.4]; P = 0.01) and greater weight loss (mean ± SD, -6.8% ± 3.5 vs. -3.1% ± 2.6; P < 0.001) and aerobic capacity (median [25th to 75th percentile], 3.0 [2.4 to 4.0] vs. 0.9 [-0.3 to 1.3] ml O2 × kg-1 × min-1; P < 0.001). These improvements in the WL + E group were also accompanied by improvements in lung function, antiinflammatory biomarkers, and vitamin D levels, as well as reductions in airway and systemic inflammation. CONCLUSIONS: Adding exercise to a short-term weight-loss program should be considered as a useful strategy for achieving clinical control of asthma in obese patients. Clinical trial registered with www.clinicaltrials.gov (NCT 02188940).


Assuntos
Asma/complicações , Exercício Físico , Obesidade/complicações , Programas de Redução de Peso/métodos , Asma/fisiopatologia , Asma/terapia , Biomarcadores/sangue , Restrição Calórica/métodos , Feminino , Humanos , Inflamação/sangue , Inflamação/fisiopatologia , Pulmão/fisiopatologia , Masculino , Pessoa de Meia-Idade , Força Muscular , Obesidade/terapia , Qualidade de Vida , Treinamento Resistido , Testes de Função Respiratória
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA